Knockdown of Long Noncoding RNA CCAT2 Suppresses Malignant Phenotype in Human Laryngeal Squamous Cell Carcinoma

M Li1, J An2, H Ren3

  • 1Department of Otolaryngology-Head and Neck Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Insights

Colon cancer-associated transcript 2 (CCAT2), a long noncoding RNA, is highly expressed in laryngeal squamous cell carcinoma (LSCC). Silencing CCAT2 inhibits LSCC cell proliferation and invasion, suggesting it as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Laryngeal squamous cell carcinoma (LSCC) is a significant health concern.
  • The role of long noncoding RNAs (lncRNAs) in LSCC pathogenesis is increasingly recognized.
  • Colon cancer-associated transcript 2 (CCAT2) is a lncRNA implicated in various cancers.

Purpose of the Study:

  • To investigate the biological role and underlying mechanism of CCAT2 in human LSCC.
  • To determine the correlation between CCAT2 expression and LSCC patient prognosis.
  • To evaluate CCAT2 as a potential therapeutic target and prognostic biomarker for LSCC.

Main Methods:

  • Quantitative real-time PCR to measure CCAT2 expression in LSCC tissues and cell lines.
  • Cell Counting Kit-8, Transwell assay, and flow cytometry to assess cell proliferation, invasion, and apoptosis.
  • In vivo LSCC xenograft model in nude mice to evaluate tumor growth.
  • Western blotting and immunohistochemistry to detect target protein expression (β-catenin, CDK8).

Main Results:

  • CCAT2 expression was significantly elevated in LSCC tissues and cells compared to normal controls.
  • High CCAT2 expression correlated with poorer 5-year overall survival in LSCC patients.
  • CCAT2 knockdown suppressed LSCC cell proliferation and invasion while promoting apoptosis.
  • In vivo, CCAT2 knockdown inhibited tumor growth, volume, and weight.
  • CCAT2 silencing down-regulated β-catenin and CDK8 expression, inhibiting the Wnt/β-catenin signaling pathway.

Conclusions:

  • CCAT2 plays a crucial role in promoting LSCC progression by enhancing proliferation and invasion.
  • CCAT2 acts, at least in part, by modulating the Wnt/β-catenin signaling pathway.
  • CCAT2 is a potential prognostic biomarker and therapeutic target for LSCC.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K